Market Cap 1.75B
Revenue (ttm) 3.55M
Net Income (ttm) -599.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -16,887.04%
Debt to Equity Ratio 7.30
Volume 1,559,000
Avg Vol 2,001,310
Day's Range N/A - N/A
Shares Out 137.32M
Stochastic %K 21%
Beta 0.92
Analysts Strong Sell
Price Target $46.07

Latest News on ARWR

Arrowhead Pharmaceuticals Is Finally Arriving

Mar 21, 2025, 5:56 PM EDT - 12 days ago

Arrowhead Pharmaceuticals Is Finally Arriving


Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results

Nov 26, 2024, 4:00 PM EST - 4 months ago

Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results


Arrowhead Pharmaceutical: Driving To Commercialization

Jul 26, 2024, 12:12 PM EDT - 8 months ago

Arrowhead Pharmaceutical: Driving To Commercialization